Gilead Sciences, Inc. (LON: 0QYQ)
London
· Delayed Price · Currency is GBP · Price in USD
92.85
+1.94 (2.13%)
At close: Dec 20, 2024
Gilead Sciences Revenue
Gilead Sciences had revenue of $7.55B USD in the quarter ending September 29, 2024, with 7.02% growth. This brings the company's revenue in the last twelve months to $28.30B, up 3.31% year-over-year. In the year 2023, Gilead Sciences had annual revenue of $27.12B, down -0.60%.
Revenue (ttm)
$28.30B
Revenue Growth
+3.31%
P/S Ratio
n/a
Revenue / Employee
$1.57M
Employees
18,000
Market Cap
91.76B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 30, 2023 | 27.12B | -165.00M | -0.60% |
Dec 30, 2022 | 27.28B | -24.00M | -0.09% |
Dec 30, 2021 | 27.31B | 2.62B | 10.60% |
Dec 30, 2020 | 24.69B | 2.24B | 9.98% |
Dec 30, 2019 | 22.45B | 322.00M | 1.46% |
Dec 30, 2018 | Pro | Pro | Pro |
Dec 30, 2017 | Pro | Pro | Pro |
Dec 30, 2016 | Pro | Pro | Pro |
Dec 30, 2015 | Pro | Pro | Pro |
Dec 30, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition